Mens Health Policy

You are here: Home » Advocacy » PCa Research Bill
Friday, 20 Oct 2017

Prostate Cancer Research and Prevention Act

E-mail Print PDF

The Prostate Cancer Research and Prevention Act will extend prostate cancer preventative-health and research programs at the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH).

By writing, emailing, or calling your members of Congress and encouraging them to become cosponsors, you can help save numerous life saving prostate cancer initiatives at the CDC and the NIH! The list below contains just some of the prostate programs at CDC and NIH.


Center for Disease Control Prostate Programs

1) Cancer registry program. This program collects data on cancer occurrences in every state. This information is reported to the state cancer registry and provides a framework for further research and analysis. Specific data and information about communities results from these analyses.

2) Comprehensive cancer control. These are partnerships the CDC has with state departments of health, national organizations, and tribal organizations. Funds are used to allow these entities to prioritize their goals and initiatives and implement activities related to prostate cancer.

3) Outreach, which focuses on Informed Decision Making. CDC provides education and resources on the pros and cons of screening. CDC also evaluates measures taken to make improvements.


National Institutes of Health Prostate Programs

NIH is conducting and supporting research to expand the understanding of the cause of, and to find a cure for, prostate cancer. NIH provides:

(1) Basic research concerning the etiology and causes of prostate cancer;

(2) Clinical research and related activities concerning the causes, prevention, detection and treatment of prostate cancer;

(3) Prevention and control and early detection programs with respect to prostate cancer, particularly as it relates to intensifying research on the role of prostate specific antigen for the screening and early detection of prostate cancer;

(4) A task force to provide coordination between relevant National Institutes of Health components of research efforts on prostate cancer;

(5) Prostate cancer control programs;

(6) Information and education programs with respect to prostate cancer and;

(7) Prostate cancer research and demonstration centers, including the development and operation of centers for prostate cancer research to bring together basic and clinical, biomedical and behavioral scientists to conduct basic, clinical, epidemiological, psychosocial, prevention and control, treatment, research, and related activities on prostate cancer.